ENOV
Enovis Corp
NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES
$22.49
-3.89% today
Updated 2026-04-29
Market cap
$1.35B
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-20.72
Dividend yield
—
52W range
$21 – $38
Volume
1.0M
Enovis Corp (ENOV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $393.60M | $506.31M | $604.85M | $525.02M | $541.99M | $693.39M | $3.91B | $4.21B | $4.62B | $3.97B | $3.65B | $3.30B | $2.19B | $3.33B | $3.07B | $1.43B | $1.56B | $1.71B | $2.11B | $2.25B |
| Revenue growth (YoY) | — | +28.6% | +19.5% | -13.2% | +3.2% | +27.9% | +464.5% | +7.5% | +9.9% | -14.2% | -8.1% | -9.5% | -33.5% | +51.7% | -7.7% | -53.6% | +9.6% | +9.2% | +23.5% | +6.7% |
| Cost of revenue | $256.81M | $330.71M | $387.67M | $339.24M | $350.58M | $453.29M | $2.76B | $2.90B | $3.15B | $2.72B | $2.50B | $2.27B | $1.46B | $1.93B | $1.78B | $648.51M | $693.72M | $716.42M | $926.87M | $902.79M |
| Gross profit | $136.80M | $175.59M | $217.19M | $185.79M | $191.41M | $240.10M | $1.15B | $1.31B | $1.48B | $1.25B | $1.15B | $1.03B | $729.38M | $1.40B | $1.29B | $777.67M | $869.38M | $990.78M | $1.18B | $1.35B |
| Gross margin | 34.8% | 34.7% | 35.9% | 35.4% | 35.3% | 34.6% | 29.4% | 31.0% | 32.0% | 31.6% | 31.4% | 31.2% | 33.3% | 42.1% | 41.9% | 54.5% | 55.6% | 58.0% | 56.0% | 59.8% |
| R&D | $3.34M | $4.16M | $5.86M | $5.93M | $6.21M | $5.71M | $19.40M | $27.40M | $43.00M | $41.50M | $39.30M | $42.90M | $34.20M | $61.80M | $34.27M | $49.09M | $60.83M | $75.33M | $91.30M | $120.33M |
| SG&A | — | — | — | — | — | — | $879.75M | $843.99M | — | — | — | — | $818.21M | $1.13B | $1.09B | $1.33B | $772.91M | $830.30M | $1.03B | $1.07B |
| Operating income | $19.54M | $123.28M | $16.69M | $38.46M | $34.37M | $25.91M | $140.01M | $406.39M | $409.55M | $284.64M | $238.01M | $29.15M | $151.54M | $203.61M | $162.29M | $-62.80M | $-71.18M | $-65.71M | $-775.72M | $-1.18B |
| Operating margin | 5.0% | 24.3% | 2.8% | 7.3% | 6.3% | 3.7% | 3.6% | 9.7% | 8.9% | 7.2% | 6.5% | 0.9% | 6.9% | 6.1% | 5.3% | -4.4% | -4.6% | -3.8% | -36.8% | -52.6% |
| EBITDA | $32.68M | $140.16M | $16.69M | $54.70M | $34.37M | $25.91M | $140.01M | $525.65M | $409.55M | $430.59M | $349.26M | $160.41M | $330.29M | $406.02M | $180.05M | $170.25M | $241.69M | $169.73M | $-481.03M | $-830.22M |
| EBITDA margin | 8.3% | 27.7% | 2.8% | 10.4% | 6.3% | 3.7% | 3.6% | 12.5% | 8.9% | 10.9% | 9.6% | 4.9% | 15.1% | 12.2% | 5.9% | 11.9% | 15.5% | 9.9% | -22.8% | -36.9% |
| EBIT | $19.54M | $123.28M | $1.90M | $39.63M | $18.24M | $3.31M | $-60.39M | $406.39M | $234.83M | $276.05M | $239.40M | $36.99M | $151.54M | $170.00M | $162.29M | $-92.67M | $21.98M | $-47.38M | $-765.82M | $-1.12B |
| Interest expense | — | — | $11.82M | $7.21M | $6.68M | $5.92M | $91.57M | $103.60M | $51.30M | $47.74M | $30.02M | $40.11M | $49.08M | $119.50M | $52.82M | $29.11M | $24.95M | $19.75M | $57.10M | $34.82M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $94000.00 | $64.88M | $-571000.00 | $21.72M | $16.21M | $4.55M | $-64.40M | $178.63M | $392.10M | $167.74M | $128.11M | $151.09M | $140.20M | $-527.65M | $42.63M | $71.66M | $-13.29M | $-33.26M | $-825.49M | $-1.18B |
| Net income growth (YoY) | — | +68923.4% | -100.9% | +3904.2% | -25.4% | -71.9% | -1513.9% | +377.4% | +119.5% | -57.2% | -23.6% | +17.9% | -7.2% | -476.4% | +108.1% | +68.1% | -118.5% | -150.2% | -2381.9% | -43.5% |
| Profit margin | 0.0% | 12.8% | -0.1% | 4.1% | 3.0% | 0.7% | -1.6% | 4.2% | 8.5% | 4.2% | 3.5% | 4.6% | 6.4% | -15.9% | 1.4% | 5.0% | -0.9% | -1.9% | -39.2% | -52.7% |